| GluN2B-containing NMDA receptors regulate depression-like behavior and are critical for the rapid antidepressant actions of ketamine OH Miller, L Yang, CC Wang, EA Hargroder, Y Zhang, E Delpire, BJ Hall elife 3, e03581, 2014 | 358 | 2014 |
| Two cellular hypotheses explaining the initiation of ketamine's antidepressant actions: Direct inhibition and disinhibition OH Miller, JT Moran, BJ Hall Neuropharmacology 100, 17-26, 2016 | 195 | 2016 |
| Sustained NPY signaling enables AgRP neurons to drive feeding Y Chen, RA Essner, S Kosar, OH Miller, YC Lin, S Mesgarzadeh, ... Elife 8, e46348, 2019 | 102 | 2019 |
| Microengineered peripheral nerve-on-a-chip for preclinical physiological testing RM Huval, OH Miller, JL Curley, Y Fan, BJ Hall, MJ Moore Lab on a Chip 15 (10), 2221-2232, 2015 | 77 | 2015 |
| Synaptic regulation of a thalamocortical circuit controls depression-related behavior OH Miller, A Bruns, IB Ammar, T Mueggler, BJ Hall Cell reports 20 (8), 1867-1880, 2017 | 62 | 2017 |
| Cross talk between glucocorticoid and estrogen receptors occurs at a subset of proinflammatory genes A Cvoro, C Yuan, S Paruthiyil, OH Miller, KR Yamamoto, DC Leitman The Journal of Immunology 186 (7), 4354-4360, 2011 | 61 | 2011 |
| Genome-wide translating mRNA analysis following ketamine reveals novel targets for antidepressant treatment OH Miller, N Grabole, I Wells, BJ Hall BioRxiv, 254904, 2018 | 4 | 2018 |
| In Vivo Cellular-Resolution Calcium Imaging Reveals Functional Biomarkers of the Antidepressant Ketamine and Guides Preclinical Efficacy Testing O Miller, L Bellier, S Huang, L Gray, J Nassi NEUROPSYCHOPHARMACOLOGY 48, 284-285, 2023 | | 2023 |
Benjamin J. HallDirector, H. Lundbeck A/SVerified email at lundbeck.com
